• Advanced Cell Technology ( Alameda California) reports it has successfully produced a human embryonic stem cell (hESC) line without destroying an embryo at its lab in Worcester, Massachusetts. This development comes on the heels of President George Bush’s veto of federal legislation which would have provided funding for embryonic stem cell research. In August 2006, ACT published a paper in Nature Magazine documenting a technique for removing a single cell (known as a blastomere) from an eight-cell human embryo, and using that cell to generate multiple hESCs without destroying the embryo. ACT is a biotech company applying embryonic stem cell technology in the emerging field of regenerative medicine.

• BodyTel Scientific (Henderson Nevada) said it has completed the first production run of the GlucoTel Meter which will be used for upcoming clinical studies and premarketing initiatives. The GlucoTel Meter is a glucose monitoring system. The meter is part of the GlucoTel, which is a complete telemedical diabetes self-management system supporting patients and doctors in the treatment of diabetes and its secondary complications. The GlucoTel blood glucose meter collects blood sugar readings and sends them to the patient’s mobile phone via Bluetooth. Afterwards, the data is automatically sent to a secure Internet database via SMS and is centrally held there long-term.